SD Nanosciences, Inc. is a spin-off of the University of Maryland. Our proprietary "Triad" technology has applications in vaccines, cancer diagnostics, and specialty research probes. Triad combines carbohydrates and proteins on nanoparticles, which enables presentation of sugars and proteins in a controlled and logical way. We are developing our platform technology and our initial products include a vaccine for N meningitides B, an optical fiber-based point-of-care diagnostic test, and a biosensor for glycoprotein bioprocessing.